1. Yamaguchi M, Seto M, Okamoto M, et al. De novo CD5+ diffuse large B-cell lymphoma: clinicopathologic study of 109 patients. Blood. 2002;99:815-821.
2. Dong HY, Gorczyca W, Liu Z, et al. B-cell lymphoma with coexpression of CD5 and CD10. Am J Clin Pathol. 2003;119:218-230.
3. Grillo-Lopez AJ. Monoclonal antibody therapy for B-cell lymphoma. Int J Hematol. 2002;76:385-393.
4. Tagawa H, Tsuzuki S, Suzuki R, et al. Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative cases. Cancer Res. 2004;64:5948-5955.
5. Yoshioka T, Miura I, Kume M, et al. Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma: chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survival. Genes Chromosomes Cancer. 2005;42:149-157.